Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 1.13B | 815.33M | 680.32M | 800.51M | 690.72M |
Gross Profit | 112.29M | 99.14M | 75.56M | 102.01M | 71.30M |
EBITDA | 11.76M | 11.70M | -22.22M | 25.80M | 23.91M |
Net Income | 8.02M | 6.14M | -27.77M | 19.43M | 16.02M |
Balance Sheet | |||||
Total Assets | 437.65M | 435.00M | 323.26M | 376.19M | 367.89M |
Cash, Cash Equivalents and Short-Term Investments | 94.59M | 20.78M | 60.31M | 120.76M | 105.31M |
Total Debt | 41.29M | 55.31M | 25.66M | 6.30M | 7.33M |
Total Liabilities | 236.85M | 243.42M | 138.13M | 167.78M | 177.00M |
Stockholders Equity | 200.79M | 191.63M | 185.13M | 208.40M | 190.90M |
Cash Flow | |||||
Free Cash Flow | 94.09M | -77.70M | -93.54M | 14.35M | 35.22M |
Operating Cash Flow | 94.13M | -77.68M | -93.15M | 14.52M | 35.65M |
Investing Cash Flow | 319.00K | 6.66M | 12.15M | 5.03M | -24.32M |
Financing Cash Flow | -14.64M | 22.36M | 13.39M | -2.83M | 76.24M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | HK$250.11M | 9.73 | 4.67% | 3.51% | 7.39% | 142.61% | |
66 Neutral | HK$235.17M | 26.74 | 4.09% | 1.57% | 35.72% | 23.53% | |
58 Neutral | HK$179.29M | ― | -6.08% | ― | 8.50% | 67.35% | |
56 Neutral | HK$13.71B | 5.12 | -5.75% | 5.43% | 9.34% | -42.23% | |
44 Neutral | HK$222.30M | ― | -37.23% | ― | 14.28% | 78.69% | |
41 Neutral | HK$212.47M | ― | ― | ― | ― | ||
39 Underperform | HK$149.19M | ― | -253.21% | ― | 79.84% | -219.70% |
Edensoft Holdings Limited held its Annual General Meeting on May 23, 2025, where all proposed resolutions were approved unanimously. The resolutions included the adoption of financial statements, approval of a final dividend, re-appointment of auditors, re-election of directors, and authorization for the board to fix directors’ remuneration, reflecting strong shareholder support and stable governance.
Edensoft Holdings Limited has announced its upcoming annual general meeting scheduled for May 23, 2025, in Shenzhen, China. Key agenda items include the adoption of the 2024 financial statements, approval of a final dividend, reappointment of auditors, re-election of directors, and authorization for directors to manage share-related transactions. These decisions are poised to impact the company’s financial management and governance structure, potentially influencing shareholder value and market perception.